+1 347 708 0418
Intracranial Atherosclerotic Disease Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intracranial Atherosclerotic Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Intracranial Atherosclerotic Disease Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intracranial Atherosclerotic Disease Treatment Sales by Region
2.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Intracranial Atherosclerotic Disease Treatment by Region (2023-2028)
2.5 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region
2.5.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022)
2.5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers
3.1.1 Global Top Intracranial Atherosclerotic Disease Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in 2021
3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers
3.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intracranial Atherosclerotic Disease Treatment Revenue in 2021
3.3 Global Intracranial Atherosclerotic Disease Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intracranial Atherosclerotic Disease Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type
4.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type
4.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2017-2022)
4.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application
5.1.1 Global Intracranial Atherosclerotic Disease Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application
5.2.1 Global Intracranial Atherosclerotic Disease Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Intracranial Atherosclerotic Disease Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application
5.3.1 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2017-2022)
5.3.2 Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intracranial Atherosclerotic Disease Treatment Market Size by Type
6.1.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
6.1.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
6.2 North America Intracranial Atherosclerotic Disease Treatment Market Size by Application
6.2.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
6.2.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
6.3 North America Intracranial Atherosclerotic Disease Treatment Market Size by Country
6.3.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2028)
6.3.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Type
7.1.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
7.1.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
7.2 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Application
7.2.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
7.2.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
7.3 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Country
7.3.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2028)
7.3.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Size by Type
8.1.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Size by Application
8.2.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Size by Region
8.3.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Type
9.1.1 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
9.1.2 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
9.2 Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Application
9.2.1 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
9.2.2 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
9.3 Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Country
9.3.1 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2028)
9.3.2 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Size by Type
10.1.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Size by Application
10.2.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Size by Country
10.3.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Stryker
11.1.1 Stryker Corporation Information
11.1.2 Stryker Overview
11.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Stryker Recent Developments
11.2 Balt
11.2.1 Balt Corporation Information
11.2.2 Balt Overview
11.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Balt Recent Developments
11.3 TERUMO
11.3.1 TERUMO Corporation Information
11.3.2 TERUMO Overview
11.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TERUMO Recent Developments
11.4 MicroPort
11.4.1 MicroPort Corporation Information
11.4.2 MicroPort Overview
11.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MicroPort Recent Developments
11.5 Acandis
11.5.1 Acandis Corporation Information
11.5.2 Acandis Overview
11.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Acandis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intracranial Atherosclerotic Disease Treatment Industry Chain Analysis
12.2 Intracranial Atherosclerotic Disease Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intracranial Atherosclerotic Disease Treatment Production Mode & Process
12.4 Intracranial Atherosclerotic Disease Treatment Sales and Marketing
12.4.1 Intracranial Atherosclerotic Disease Treatment Sales Channels
12.4.2 Intracranial Atherosclerotic Disease Treatment Distributors
12.5 Intracranial Atherosclerotic Disease Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
13.2 Intracranial Atherosclerotic Disease Treatment Market Drivers
13.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
13.4 Intracranial Atherosclerotic Disease Treatment Market Restraints
14 Key Findings in The Global Intracranial Atherosclerotic Disease Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Stent
Table 3. Major Manufacturers of PTA Balloon
Table 4. Global Intracranial Atherosclerotic Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 7. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2022)
Table 8. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2023-2028) & (K Units)
Table 9. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2023-2028)
Table 10. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2017-2022)
Table 12. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2023-2028)
Table 14. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Manufacturers (2017-2022)
Table 16. Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Manufacturers (2017-2022)
Table 18. Intracranial Atherosclerotic Disease Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Intracranial Atherosclerotic Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2021)
Table 21. Intracranial Atherosclerotic Disease Treatment Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intracranial Atherosclerotic Disease Treatment Product Offered
Table 23. Date of Manufacturers Enter into Intracranial Atherosclerotic Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 26. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 27. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2017-2022)
Table 28. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Type (2023-2028)
Table 29. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2017-2022)
Table 32. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Type (2023-2028)
Table 33. Intracranial Atherosclerotic Disease Treatment Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 36. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 37. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2017-2022)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Application (2023-2028)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2017-2022)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Application (2023-2028)
Table 43. Intracranial Atherosclerotic Disease Treatment Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Intracranial Atherosclerotic Disease Treatment Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 46. North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 47. North America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 50. North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 51. North America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 54. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 55. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 58. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 59. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 62. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 63. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 66. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 67. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 105. Stryker Corporation Information
Table 106. Stryker Description and Major Businesses
Table 107. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Stryker Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Stryker Recent Developments
Table 110. Balt Corporation Information
Table 111. Balt Description and Major Businesses
Table 112. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Balt Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Balt Recent Developments
Table 115. TERUMO Corporation Information
Table 116. TERUMO Description and Major Businesses
Table 117. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. TERUMO Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. TERUMO Recent Developments
Table 120. MicroPort Corporation Information
Table 121. MicroPort Description and Major Businesses
Table 122. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. MicroPort Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. MicroPort Recent Developments
Table 125. Acandis Corporation Information
Table 126. Acandis Description and Major Businesses
Table 127. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Acandis Intracranial Atherosclerotic Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Acandis Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Intracranial Atherosclerotic Disease Treatment Distributors List
Table 133. Intracranial Atherosclerotic Disease Treatment Customers List
Table 134. Intracranial Atherosclerotic Disease Treatment Market Trends
Table 135. Intracranial Atherosclerotic Disease Treatment Market Drivers
Table 136. Intracranial Atherosclerotic Disease Treatment Market Challenges
Table 137. Intracranial Atherosclerotic Disease Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Intracranial Atherosclerotic Disease Treatment Product Picture
Figure 3. Global Intracranial Atherosclerotic Disease Treatment Market Share by Type in 2021 & 2028
Figure 3. Stent Product Picture
Figure 4. PTA Balloon Product Picture
Figure 5. Global Intracranial Atherosclerotic Disease Treatment Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Intracranial Atherosclerotic Disease Treatment Report Years Considered
Figure 10. Global Intracranial Atherosclerotic Disease Treatment Sales 2017-2028 (K Units)
Figure 11. Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Intracranial Atherosclerotic Disease Treatment Revenue 2017-2028 (US$ Million)
Figure 13. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2022)
Figure 15. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2023-2028)
Figure 16. North America Intracranial Atherosclerotic Disease Treatment Sales YoY (2017-2028) & (K Units)
Figure 17. North America Intracranial Atherosclerotic Disease Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Intracranial Atherosclerotic Disease Treatment Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Intracranial Atherosclerotic Disease Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Intracranial Atherosclerotic Disease Treatment Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Intracranial Atherosclerotic Disease Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Intracranial Atherosclerotic Disease Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Intracranial Atherosclerotic Disease Treatment in the World: Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2021
Figure 28. Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 30. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 31. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 32. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 33. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 34. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 35. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 36. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 37. North America Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2017-2028)
Figure 38. North America Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2017-2028)
Figure 39. U.S. Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 42. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 43. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 44. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2017-2028)
Figure 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2017-2028)
Figure 47. Germany Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 48. France Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue Share by Region (2017-2028)
Figure 58. China Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. India Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 69. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 71. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2017-2028)
Figure 73. Latin America Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2017-2028)
Figure 74. Mexico Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue Share by Country (2017-2028)
Figure 83. Turkey Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (US$ Million)
Figure 86. Intracranial Atherosclerotic Disease Treatment Value Chain
Figure 87. Intracranial Atherosclerotic Disease Treatment Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Buy
